Form 4: DENTSPLY SIRONA Exec Boosts Equity Holdings

DENTSPLY SIRONA's SVP, CHRO, Andrea L. Frohning, increased her beneficial ownership of company stock through RSU dividends and phantom stock acquisitions.

Summary

• Andrea L. Frohning, SVP, CHRO of DENTSPLY SIRONA Inc. (XRAY), acquired 357.053 shares of Common Stock on October 10, 2025.
• These shares represent dividends on restricted stock units (RSUs) awarded to the Reporting Person, issued in the form of additional RSUs, and are subject to the same vesting terms as the underlying awards.
• The dividends vest simultaneously with the RSUs to which they relate, with each RSU converting to common stock on a 1:1 basis.
• Following this transaction, Andrea L. Frohning directly beneficially owns 33,609.865 shares of Common Stock.
• Additionally, 22.893 shares of Phantom Stock (Supplemental Executive Retirement Plan SERP) were acquired on October 10, 2025, at a price of $11.98 per share.
• These phantom stock shares are comprised of accrued dividends and are the economic equivalent of one share of common stock, becoming payable in common stock upon the reporting person's termination of employment.
• Following this transaction, Andrea L. Frohning directly beneficially owns 1,736.5455 shares of Phantom Stock.

Sentiment

Score: 7

Explanation: The filing indicates a routine, positive action of an executive increasing their equity holdings through compensation plans, which generally signals confidence. It is not a major event but a consistent positive signal.

Positives

• Increased insider ownership signals continued confidence in the company's future performance by a key executive.
• The acquisition of shares through dividend reinvestment demonstrates the executive's participation in and commitment to the company's equity compensation plans.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting terms of the RSUs and the payout conditions of the phantom stock upon termination of employment.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information directly related to broader industry trends or competitive landscape. It reflects an executive's participation in standard equity compensation and dividend reinvestment plans within the dental technology and healthcare industry.

Stakeholder Impact

• Shareholders: The increase in insider ownership can be viewed as a positive signal of management's alignment with shareholder interests and confidence in the company's future.

Next Steps

• The acquired Restricted Stock Units (RSUs) will vest according to the terms of the underlying awards.
• The phantom stock will become payable in common stock upon the reporting person's termination of employment.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by an executive through dividend reinvestment and phantom stock accrual. While it is a positive signal of insider confidence, it does not provide new fundamental information or strategic changes that would warrant an alteration to an existing investment thesis or a strong buy/sell recommendation based solely on this filing.

Keywords

DENTSPLY SIRONA, XRAY, Insider Transaction, Form 4, Executive Compensation, Restricted Stock Units, Phantom Stock, Equity Holdings